McMaster Trial Receives $6.7M to Test If a Smallpox Vaccine Can Provide Protection Against Mpox Post-Exposure
August 03, 2024
August 03, 2024
HAMILTON, Ontario, Aug. 3 (TNSres) -- McMaster University issued the following news:
By Adam Ward
Researchers with McMaster University are leading a clinical trial that will assess whether a smallpox vaccine can provide protection against mpox after someone has come in contact with the infection.
The Smallpox vaccine for Mpox Post-Exposure Prophylaxis: A Cluster Randomized Controlled Trial (SMART) will launch in the Democratic Republic of Congo (DRC) and ot . . .
By Adam Ward
Researchers with McMaster University are leading a clinical trial that will assess whether a smallpox vaccine can provide protection against mpox after someone has come in contact with the infection.
The Smallpox vaccine for Mpox Post-Exposure Prophylaxis: A Cluster Randomized Controlled Trial (SMART) will launch in the Democratic Republic of Congo (DRC) and ot . . .